Prognostic value of two tumour staging classifications in patients with sinonasal mucosal melanoma
- PMID: 27291483
- DOI: 10.1016/j.anorl.2016.05.008
Prognostic value of two tumour staging classifications in patients with sinonasal mucosal melanoma
Abstract
Introduction: Sinonasal mucosal melanoma is a rare disease associated with a very poor prognosis. The purpose of this study was to assess the prognostic value of the 2 staging systems published in the literature for these tumours: the American Joint Committee on Cancer (AJCC) Cancer Staging Manual for mucosal melanoma of the head and neck published in 2009 (7th edition) and the AJCC Cancer Staging Manual for cancers of the nasal cavity and paranasal sinuses published in 2002 (6th edition) and the prognostic value of tumour site, either limited to the nasal cavities or with paranasal sinus invasion.
Methods: A retrospective study was conducted on 18 patients treated between August 1998 and June 2014. Each lesion was staged according to the AJCC Cancer Staging Manual 2002 and 2009 and the following data were collected: age, sex, tumour site, initial symptoms, treatment modalities, follow-up, recurrences and overall survival. Patient survival, from the date of discovery of the melanoma until death, was analysed by Kaplan-Meier survival curves and between-group comparison of survival was performed with a log rank test.
Results: The mean age at diagnosis was 72 years (range: 54-94) and the cohort comprised 11 women and 7 men. The median overall survival was 80 months, the 1-year overall survival was 82.6% and the 5-year overall survival was 54.5%. The AJCC 2002 staging system presented a statistically significant prognostic value (P=0.0476), while no statistically significant prognostic value was observed for the AJCC 2009 staging system (P=0.108). Paranasal sinus invasion was significantly associated with a poor prognosis (P=0.0039).
Conclusion: This study demonstrates the superiority of the non-specific AJCC 2002 Cancer Staging Manual. Medical and surgical management must take paranasal sinus invasion into account, as it constitutes a major prognostic factor.
Keywords: Overall survival; Prognostic value; Sinonasal mucosal melanoma; Staging systems.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.
Similar articles
-
Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France.Eur J Cancer. 2019 Dec;123:1-10. doi: 10.1016/j.ejca.2019.09.007. Epub 2019 Oct 24. Eur J Cancer. 2019. PMID: 31670075
-
Sinonasal mucosal melanomas: the prognostic value of tumor classifications.Head Neck. 2014 Mar;36(3):311-6. doi: 10.1002/hed.23298. Epub 2013 Jun 1. Head Neck. 2014. PMID: 23729399
-
Demographics and treatment trends in sinonasal mucosal melanoma.Laryngoscope. 2011 Sep;121(9):2026-33. doi: 10.1002/lary.21925. Epub 2011 Aug 16. Laryngoscope. 2011. PMID: 22024859
-
Mucosal melanoma of the nasal cavity and paranasal sinuses.Eur Ann Otorhinolaryngol Head Neck Dis. 2014 Dec;131(6):365-369. doi: 10.1016/j.anorl.2013.11.004. Epub 2014 Jun 3. Eur Ann Otorhinolaryngol Head Neck Dis. 2014. PMID: 24906226 Review.
-
Cancer of the Nasal Cavity, Middle Ear and Accessory Sinuses - 15 Year Comparative Survival and Mortality Analysis by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration and Topographic Primary Sites: A Systematic Review of 13,404 Cases for Diagnosis Years 2000-2017: (NCI SEER*Stat 8.3.8).J Insur Med. 2024 Jul 1;51(2):77-91. doi: 10.17849/insm-51-2-77-91.1. J Insur Med. 2024. PMID: 39266003
Cited by
-
Primary tumor volume as a predictor of distant metastases and survival in patients with sinonasal mucosal melanoma.Head Neck. 2020 Nov;42(11):3316-3325. doi: 10.1002/hed.26380. Epub 2020 Aug 1. Head Neck. 2020. PMID: 32737953 Free PMC article.
-
Primary Sinonasal Malignant Melanoma: Effect of Clinical and Histopathologic Prognostic Factors on Survival.Balkan Med J. 2017 May 5;34(3):255-262. doi: 10.4274/balkanmedj.2016.0503. Epub 2017 Apr 6. Balkan Med J. 2017. PMID: 28443572 Free PMC article.
-
International Multicenter Study of Clinical Outcomes of Sinonasal Melanoma Shows Survival Benefit for Patients Treated with Immune Checkpoint Inhibitors and Potential Improvements to the Current TNM Staging System.J Neurol Surg B Skull Base. 2022 Jul 10;84(4):307-319. doi: 10.1055/s-0042-1750178. eCollection 2023 Aug. J Neurol Surg B Skull Base. 2022. PMID: 37405239 Free PMC article.
-
Survival Outcomes in Sinonasal Mucosal Melanoma: Systematic Review and Meta-Analysis.J Pers Med. 2024 Nov 26;14(12):1120. doi: 10.3390/jpm14121120. J Pers Med. 2024. PMID: 39728033 Free PMC article. Review.
-
Undifferentiated sinonasal malignant melanoma: A case report.Oncol Lett. 2018 Jul;16(1):580-584. doi: 10.3892/ol.2018.8662. Epub 2018 May 8. Oncol Lett. 2018. PMID: 29930718 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical